General Announcement::ASX:NASDAQ:TLX: FDA Accepts NDA for TLX101-Px (Pixclara)

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
10-Apr-2026 06:29:38
Status
New
Announcement Sub Title
ASX:NASDAQ:TLX: FDA Accepts NDA for TLX101-Px (Pixclara)
Announcement Reference
SG260410OTHRNFZA
Submitted By (Co./ Ind. Name)
Nick Golding
Designation
Assistant Company Secretary
Effective Date and Time of the event
10/04/2026 06:30:00
Description (Please provide a detailed description of the event in the box below)
ASX:NASDAQ:TLX: FDA Accepts NDA for TLX101-Px (Pixclara)

Attachments

20260410 Pixclara NDA acceptance vFINAL.pdf
Total size =210K